These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4447577)

  • 1. Electroencephalographic changes in women treated with contraceptive steroids.
    Gautray JP; Eberhard A; Jalivet A; Leygonie G
    Basic Life Sci; 1974; 4(PART A):385-97. PubMed ID: 4447577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology of hormonal contraceptives].
    Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M
    Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Daily fluctuation of the follicle-stimulating (FSH) and luteinizing (LH) hormone in the human plasma].
    Leyendecker G; Saxena BB
    Klin Wochenschr; 1970 Feb; 48(4):236-8. PubMed ID: 5523315
    [No Abstract]   [Full Text] [Related]  

  • 8. [Testing of the steroid-related suppressive effect on the hypothalamo-hypophyseal system using twofold stimulation].
    Carol W; Lauterbach H; Klinger G
    Zentralbl Gynakol; 1984; 106(6):359-67. PubMed ID: 6426199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of combined oral contraceptive steroids on the gonadotropin responses to LH-RH in lactating women with regular menstrual cycles resumed.
    Ryu K; Hong SS
    Contraception; 1983 Jun; 27(6):605-17. PubMed ID: 6413131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
    Snowden EU; Khan-Dawood FS; Dawood MY
    Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
    Ryu K; Yu HK; Kwak HM; Hong SS
    Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M; Morris SE; Groom GV; Jenner DA; Scarisbrick JJ; Cameron EH
    Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive.
    Spona J; Schneider WH
    Acta Obstet Gynecol Scand Suppl; 1976; 54():45-50. PubMed ID: 788444
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
    Lähteenmäki P
    Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women.
    Swerdloff RS; Odell WD
    J Clin Endocrinol Metab; 1969 Feb; 29(2):157-63. PubMed ID: 4179302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Partial inhibition of the excretion of the luteinizing hormone (LH) in the female urine by anti-ovulatory compounds].
    Morató Manaro J; Maggiolo J; Michelotti M; De Spremolla IM
    Med Klin; 1967 Nov; 62(47):1840-2. PubMed ID: 5591968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.